Multiple Sclerosis

A Medically Supervised, Trauma-Informed Pathway in Portugal

Living with MS can feel like living with an unpredictable nervous system. Symptoms can shift, flare, ease, then return in a different form, leaving you constantly adapting. If you are exploring ibogaine for multiple sclerosis as part of a deeper reset, our role is to offer a safe, structured, medically supervised setting, plus the therapeutic support needed to turn insight into lasting change.

Why People Explore Ibogaine for Multiple Sclerosis

Multiple sclerosis involves immune-mediated damage to myelin and nerve signalling in the brain and spinal cord, which can translate into fatigue, pain, mobility issues, sensory changes, cognitive fog, and mood strain.

Many people who apply to us are not looking for another “miracle”. They are looking for a different angle, one that addresses the whole system: nervous system regulation, stress physiology, emotional load, and the lived reality of long-term symptoms.

Nervous System Reset and Stress Load

MS is not “all in the mind”, but the nervous system and immune system are in constant conversation.

Chronic stress physiology can amplify inflammation and symptom intensity over time, and many people with MS carry a secondary layer of trauma, burnout, or grief that conventional care rarely has time to hold.

Research on neuroimmune conditions highlights the central role of neuroinflammation in MS-related damage and symptom progression.

Neuroplasticity and Repair Pathways

Ibogaine is pharmacologically complex, with downstream effects that have been associated with neurotrophic signalling and structural neural change in other contexts.

In preclinical studies, ibogaine administration has been shown to modify expression of neurotrophic factors including BDNF and GDNF in brain regions involved in neural adaptation.

There are also studies reporting changes in myelin-related markers following ibogaine exposure in animals.

This is one reason some people explore ibogaine for multiple sclerosis with a focus on myelin repair and function-supporting neuroplasticity.

What the Research and Clinical Reporting Suggests

Clinical reporting relevant to MS is emerging. A published case report described significant lesion reduction and neural structural changes following ibogaine treatments in two individuals with MS, alongside clinical improvements reported by the patients.

Separately, wider psychedelic medicine literature discusses immunomodulatory and stress- normalisation pathways that may be relevant to autoimmune conditions.

Our stance is simple: we take the potential seriously, we do not overpromise outcomes, and we build the process around safety, preparation, and aftercare.

Safety First: Ibogaine Safety Screening and Medical Monitoring

Ibogaine is powerful, and it needs to be treated with respect. There is a known cardiac arrhythmia risk mechanism related to QT prolongation, which is why medical screening and monitoring matter.

At Tabula Rasa Retreat, medically supervised ibogaine means:

A physician-led process and close nursing oversight, including continuous monitoring during treatment.
Pre-arrival testing and a full review of medical history, medication, and risk factors.
Clear inclusion and exclusion criteria, aligned with established safety guidance.

If you are living with relapsing remitting MS or any other MS subtype, we will look carefully at your full picture, including current medications, symptom stability, and travel readiness, before considering admission.

What Treatment Looks Like at Tabula Rasa Retreat

We run an integrated process designed to support both the acute ibogaine experience and the weeks and months that follow.

Preparation

You submit your application, we review it clinically, and we guide you through preparation steps designed to reduce risk and improve outcomes.

Treatment and Monitoring

Treatment happens in a calm, medically monitored setting with a strong focus on safety and nervous system support.

Integration and Ibogaine Aftercare

Insight without structure fades. Our programme emphasises integration and ibogaine aftercare, so what opens up during treatment can become practical change in daily life.

This matters for MS specifically, because improvements people hope for often relate to day- to-day function: energy management, stress resilience, sleep quality, pain perception, and emotional steadiness, including MS fatigue.

If you are not ready to apply yet, take your time exploring our PDF on multiple sclerosis or other resources. And whatever you decide, remember: you do not have to navigate this alone.

Multiple Sclerosis